Primary fallopian tube carcinoma: The prognostic impact of stage, histopathology and biological parameters

International Journal of Gynecological Cancer

Volumn 6, Issue 6, 1996, Pages 456-462

  Hellstrom A C ^a   Frankendal, B ^a   Nilsson, B ^a   Pettersson, F ^a   Silfversward C ^a   Auer, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

cell proliferation; p53; ploidy; primary fallopian tube cancer; staging; tumor angiogenesis

Indexed keywords

PROTEIN P53;

ADULT; ANEUPLOIDY; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION; UTERINE TUBE CARCINOMA;

EID: 0029798488     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06060456.x     Document Type: Article

References (21)

1. Rosen AC, Reiner A, Klein M, et al. Prognostic factors in primary fallopian tube carcinoma. Gynecol Oncol 1994; 53: 307-13.
2. Sedlis A. Carcinoma of the fallopian tube. Surg Clin North Amer 1978; 58: 121.
3. Hanton E, Malkasian G, Dahlin D, Pritt J. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1966; 94: 832-9.
4. Muntz H, Tarraza H, Goff B, et al. Combination chemotherapy in advanced adenocarcinoma of the fallopian tube. Gynecol Oncol 1991; 40: 268.
5. Barakat R, Rubin S, Saigo P, et al. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol 1991; 42; 156-60.
6. Hellström A-C, Silfverswärd C, Nilsson B, Pettersson F. Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series. Int J Gynecol Cancer 1994; 4: 395-400.
7. Hellström A-C, Hue J, Silfverswärd C, Auer G. DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer. Int J Gynecol Cancer 1994; 4: 408-13.
8. Pettersson F. Staging rules for gestational trophoblastic tumors and fallopian tube cancer. Acta Obstet Gynecol Scand 1992; 71: 224-5.
9. Hu C, Taymor M, Hertig, A. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1950; 59: 58-67.
10. Auer G, Caspersson T, Wallgren A. DNA-content and survival in mammary carcinoma. Analyt Quant Cytol 1980; 2: 161-5.
11. Schimmelpenning H, Eriksson E, Zetterberg A, Auer G. Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas. World J Surg 1994; 18: 827-33.
12. Cattoretti G, Becker M, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathology 1992; 168: 357-63.
13. Key G, Becker M, Baron B, et al. New Ki-67- equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expresses parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993; 68 (No. 6): 629-36.
14. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Nat Cancer Inst 1992; 84 (No. 24): 1875-87.
15. Breslow NE, Day NE. Statistical methods in cancer research. The Analysis of Case-control Studies Vol. 1. Lyon, 1980: 192-246.
16. Deppe G, Malone M Jr, Lawrence W. Cancer of the fallopian tube. In: Gusberg S, Shingleton H, Deppe G, eds. Female Genital Cancer. New York: Churchill Livingstone, 1988; 427-34.
17. Baekelandt M, Kockx M, Wesling F, Gerris J. Primary adenocarcinoma of the fallopian tube. Review of the literature. Int J Gynecol Cancer 1993; 3: 65-71.
18. Rosen AC, Sevalda P, Klein M, et al. A comparative analysis of management and prognosis in stage I and stage II Fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer 1994; 69: 577-9.
19. Rosen AC, Graf AH, Klein M, et al. DNA-ploidy in primary fallopian tube carcinoma using image cytometry. Int J Cancer 1994; 58: 362-5.
20. Callahan R. p53 mutations another breast cancer prognostic factor. J Natl Cancer Inst 1992; 84: 826.
21. Pines J. p21 inhibits cyclin shock. Nature 1994; 369: 520-1.